new "designer estrogen," Evista
Lilly is now promoting their new "designer estrogen," Evista.
It'll be used as an alternative to estrogen...to prevent osteoporosis in postmenopausal women.
Evista (raloxifene) is a selective estrogen receptor modulator...in the same class as tamoxifen. It mimics the effects of estrogen in some tissues...but not in others.